Hey Google, tell me about the importance of living Development Reports with Kyriakos Michailaros

The White Coat Effect is Real – The Role of Person in Plant Discussion with Daniel Torok
October 2, 2020
Taking Medicines Back to The Future – A Discussion with Hedley Rees on Value Chain vs. Supply Chain: What’s the Difference?
October 16, 2020

Hey Google, tell me about the importance of living Development Reports with Kyriakos Michailaros

Episode Summary

Kyriakos Michailaros is Head of Drug Products Services at Design Space InPharmatics. With over twenty years of experience in exploratory, clinical phase and commercial projects within the pharmaceutical industry, Kyriakos brings a wealth of knowledge to today’s show. In this episode, Kyriakos, Ed, Meranda and Brian discuss product development reports, the important role that timing plays in these reports and trends in drug product manufacturing. Kyriakos shares specific examples from his career that showcase how influential these development reports have become with reviewers in the industry.

What We Covered

  • 00:53 – Kyriakos Michailaros joins the show to share his background and expertise in the subject matter of drug product services
  • 02:59 – Kyriakos shares his thoughts on appropriate timing for a development report, the validation process and the importance of having your development report be a living document
  • 08:53 – Addressing risks and concerns as it pertains to drug development programs and what Kyriakos looks for in a comprehensive development report
  • 14:56 – Kyriakos speaks to the standards he looks for in development programs when determining dosage form and the value of efficient documentation
  • 21:49 – The importance Kyriakos places on stability data and proper documentation
  • 30:03 – Kyriakos explains tablet friability, pan coating, the Ishikawa fishbone diagram and elaborates on the strangest dosage form he’s ever come across
  • 40:02 – Ed, Brian and Meranda thank Kyriakos for joining the show

Tweetable Quotes

I think it’s never too early. Ideally you want to have the story of the development program pretty much summarized by the time you’re making an NDA submission. Click To Tweet A good development program is gonna do risk assessments at certain points along the way and assess what are the major concerns associated with developing this drug product. Click To Tweet Particles tend to de-mix and segregate based on size. Click To Tweet Some reviewers, it seems, can be primarily box checking, take less of a holistic risk based approach, which has been the trend for some time now. I try to focus on what is actually important for this particular product and has that… Click To Tweet If you’re not gonna have a working development report, what you need to have is a working document repository with a file structure that can be easily followed so that you can go back and know what you have and piece together a… Click To Tweet

Links Mentioned

Design Space InPharmatics – LinkedIn

Design Space InPharmatics – Twitter

Kyriakos Michailaros on LinkedIn

Link to Hey Google, Tell Me About the Importance of Living Development Reports